Discover Our Mission and Vision for Future Success
Founded by Daphne Koller, insitro combines automated high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapeutics.
Core Innovation and Impact Metrics
Discover our key milestones and performance drivers in AI-driven drug discovery.
2018
Founded Year
Established in South San Francisco to revolutionize therapeutics development.
100
Expert Team
Dedicated professionals combining biology and machine learning.
50
Active Programs
Targeted therapies advancing through our automated discovery platform.
Discovering Breakthroughs in Drug Discovery
We combine automated high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapeutics.
Pioneering AI-Driven Therapeutics for Patients
Founded by Daphne Koller in South San Francisco, insitro integrates robust machine learning with wet lab biology to transform how new medicines are discovered and developed.
Driving Innovation in Modern Biotechnology
Our multidisciplinary team leverages advanced technology platforms to tackle complex diseases and accelerate the path from biological insight to clinical success.
Redefining Research Through Machine Learning
By scaling data generation and predictive modeling, we uncover novel insights that empower our partners to design precision therapies more efficiently.
